Login / Signup

Immunological basis for enhanced immunity of nanoparticle vaccines.

Hannah G KellyStephen J KentAdam K Wheatley
Published in: Expert review of vaccines (2019)
In the near future, increasingly complex nanoparticle vaccines displaying multiple antigens and/or co-delivered adjuvants will reach clinical trials. An improved mechanistic understanding of nanoparticle vaccination will ultimately facilitate the rational design of improved vaccines for human health.
Keyphrases
  • human health
  • risk assessment
  • clinical trial
  • iron oxide
  • climate change
  • dendritic cells
  • current status
  • phase ii
  • study protocol